Nanoform Finland Oyj (HEL: NANOFH)

Market Cap	158.07M
Revenue (ttm)	2.68M
Net Income (ttm)	-21.67M
Shares Out	85.45M
EPS (ttm)	-0.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,714
Open	1.846
Previous Close	1.846
Day's Range	1.762 - 1.850
52-Week Range	1.500 - 3.500
Beta	0.75
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2024

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharmaceutical and biotech industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients, as well as designs and develops nanoformed drug substance. It also offers STARMAP, as a secure online portal to perform large numbers of in-silico CESS experiments The company was founded in 2008 and is headquarte...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 165
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NANOFH

Financial Performance

In 2023, NANOFH's revenue was 2.57 million, a decrease of -26.41% compared to the previous year's 3.49 million. Losses were -20.76 million, -5.98% less than in 2022.